Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Journal for Immunotherapy of Cancer|January 24, 2018
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerationsJun Gong, Alexander Chehrazi-Raffle, Srikanth Reddi, et al.
Oncotarget|July 17, 2024
Targeting the multifaceted BRAF in cancer: New directionsEamon Toye, Alexander Chehrazi-Raffle, Justin Hwang, et al.
Cancers|March 6, 2021
Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial CarcinomaAlexander Chehrazi-Raffle, Tanya B Dorff, Sumanta K Pal, et al.
Clinical and Translational Medicine|March 20, 2019
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategiesJun Gong, Alexander Chehrazi-Raffle, Veronica Placencio-Hickok, et al.
Cancers|February 11, 2023
An Update on the Treatment of Papillary Renal Cell CarcinomaNeal S Chawla, Nicolas Sayegh, Sweta Prajapati, et al.
Cancer Journal (Sudbury, Mass.)|September 18, 2020
Immune Related Adverse Events: Classification and Management Approaches in Advanced Kidney CancerZeynep B Zengin, Nicholas J Salgia, Alexander Chehrazi-Raffle, et al.
The Oncologist|June 14, 2023
Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation TrialPedro C Barata, Alexander Chehrazi-Raffle, Kimberly D Allman, et al.
JCO Precision Oncology|May 18, 2026
Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing ALK Alteration Prolongs Treatment DurationVitor Abreu de Góes, Matthew Lee, Miguel Zugman, et al.
Journal for Immunotherapy of Cancer|March 10, 2021
Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinomaAlexander Chehrazi-Raffle, Luis Meza, Marice Alcantara, et al.
Cancers|October 16, 2025
Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder CancerSalvador Jaime-Casas, Wesley Yip, Daniel J Lama, et al.
Pageof 10